IMMURON LTD-SPON ADR (IMRN)

Company Profile

Immuron Ltd. is a biopharmaceutical company, which focuses on the development and commercialization of a novel class of specifically targeted polyclonal antibodies. The company is headquartered in Melbourne, Victoria and currently employs 6 full-time employees. The company operates through two segments: Research and development (R&D), and Hyperimmune products. The R&D segment is focused on R&D projects in Australia, Israel and the United States. The firm's flagship commercial products consist of Travelan and Protectyn. Travelan is an over the counter orally administered passive immunotherapeutic product indicated to reduce the risk of travelers' diarrhea, reduce the risk of minor gastro-intestinal disorders and is antimicrobial. Protectyn is sold online and in health practitioner clinics and is marketed as an immune supplement to help maintain a healthy digestive function and liver. The firm has four clinical programs -Travelan (IMM-124E), CampETEC, IMM-529 and Travelan (consumer product).

Company Info

IMMURON LTD-SPON ADR

L 3 62 Lygon St

Melbourne VICTORIA 3053

P: 61398245254

CEO: Jerry Kanellos

Employees: 6

Website: https://www.immuron.com.au